Altshuler Shaham’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18
| Closed | -$18.9K | – | 393 |
|
|
2024
Q3 | $18.9K | Buy |
+18
| New | +$18.9K | ﹤0.01% | 188 |
|
|
2023
Q3 | – | Sell |
-412
| Closed | -$296K | – | 327 |
|
|
2023
Q2 | $296K | Sell |
412
-132
| -24% | -$94.8K | 0.01% | 94 |
|
|
2023
Q1 | $447K | Sell |
544
-106
| -16% | -$87.1K | 0.01% | 76 |
|
|
2022
Q4 | $469K | Sell |
650
-276
| -30% | -$199K | 0.02% | 67 |
|
|
2022
Q3 | $641K | Sell |
926
-285
| -24% | -$197K | 0.02% | 86 |
|
|
2022
Q2 | $716K | Buy |
1,211
+1,062
| +713% | +$628K | 0.01% | 84 |
|
|
2022
Q1 | $104K | Sell |
149
-47
| -24% | -$32.8K | ﹤0.01% | 250 |
|
|
2021
Q4 | $124K | Sell |
196
-149,984
| -100% | -$94.9M | ﹤0.01% | 274 |
|
|
2021
Q3 | $146K | Buy |
150,180
+149,259
| +16,206% | +$145K | ﹤0.01% | 273 |
|
|
2021
Q2 | $515K | Buy |
921
+127
| +16% | +$71K | ﹤0.01% | 198 |
|
|
2021
Q1 | $376K | Sell |
794
-39
| -5% | -$18.5K | ﹤0.01% | 139 |
|
|
2020
Q4 | $402K | Sell |
833
-1,210
| -59% | -$584K | 0.01% | 123 |
|
|
2020
Q3 | $1.14M | Buy |
2,043
+1,273
| +165% | +$713K | 0.03% | 72 |
|
|
2020
Q2 | $480K | Buy |
770
+692
| +887% | +$431K | 0.01% | 101 |
|
|
2020
Q1 | $38K | Sell |
78
-3,327
| -98% | -$1.62M | ﹤0.01% | 197 |
|
|
2019
Q4 | $1.28M | Buy |
+3,405
| New | +$1.28M | 0.04% | 70 |
|
|
2019
Q3 | – | Sell |
-4,424
| Closed | -$1.39M | – | 538 |
|
|
2019
Q2 | $1.39M | Buy |
4,424
+4,379
| +9,731% | +$1.37M | 0.06% | 62 |
|
|
2019
Q1 | $18K | Buy |
45
+24
| +114% | +$9.6K | ﹤0.01% | 195 |
|
|
2018
Q4 | $8K | Buy |
+21
| New | +$8K | ﹤0.01% | 202 |
|
|
2018
Q1 | – | Sell |
-5,731
| Closed | -$2.16M | – | 219 |
|
|
2017
Q4 | $2.16M | Buy |
+5,731
| New | +$2.16M | 0.31% | 28 |
|